Betting Big on Gene Therapy: Pfizer Partners with Spark Therapeutics for Hemophilia Treatment

Gene therapy has seen disappointments and safety concerns in the past but Pfizer is establishing a gene therapy platform and is working with biotech company Spark Therapeutics to develop a treatment for Hemophilia B. Here's why.